• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    (OP:ONNVF)

    0.2726 UNCHANGED
    Streaming Delayed Price Updated: 2:32 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about ONNVF

    < Previous 1 2 3 4 Next >
    NetworkNewsBreaks – Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) Preps ONC010 for Clinical Translation
    Via Investor Brand Network
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO)(OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) and Redwood AI (CSE: AIRX) (OTCQB: RDWCF) Awarded Digital Health Innovation Fund Grant for AI-Driven Oncology Platform
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    Onco-Innovations and Redwood AI Secure Terry Fox Research Institute Grant to Advance AI-Powered SynoGraph(TM) Oncology Platform
    From Redwood AI Corp.
    Via ACCESS Newswire
    InvestorNewsBreaks – Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) Aligns Manufacturing, Preclinical Work and Clinical Planning for ONC010
    Via Investor Brand Network
    From Molecule to Medicine: Onco-Innovations Aligns ONC010 for Clinical Development
    Via Investor Brand Network
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generation
    Via Investor Brand Network
    News headline image
    Onco-Innovations Announces Closing of Shares for Debt Settlement
    Calgary, Canada – September 16, 2026 – TheNewswire – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce the closing... 
    Via TheNewswire.com
    BioMedNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) CMO Discusses ONC010, Novel PNKP Target in BioMedWire Podcast
    Via Investor Brand Network
    News headline image
    Onco-Innovations Provides Interim Report on Microsome Studies Across Three Species
     
    Via TheNewswire.com
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) Builds Manufacturing, IND and Capital Foundation Ahead of Planned Clinical Translation
    Via Investor Brand Network
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Enters LOI for Exclusive Option on LAG-3 Inhibitor Program
    Via Investor Brand Network
    News headline image
    Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
    From Onco-Innovations Limited
    Via ACCESS Newswire
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Builds Foundation for Biomarker-Driven Cancer Therapy
    Via Investor Brand Network
    NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Combines Targeted Cancer Therapy, Nanotechnology and AI
    Via Investor Brand Network
    Topics Artificial Intelligence
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Closes CAD$5 Million Private Placement to Advance Oncology Programs
    Via Investor Brand Network
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Moves Lead Oncology Candidate Toward Future Clinical Studies
    Via Investor Brand Network
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Combining Three Emerging Frontiers in Cancer Drug Development
    Via Investor Brand Network
    Topics Artificial Intelligence
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Precision Oncology as Biomarker-Driven Cancer Gains Momentum
    Via Investor Brand Network
    BioMedNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Completes Analytical Reference Standard Program for ONC010
    Via Investor Brand Network
    News headline image
    Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
    From Onco-Innovations Limited
    Via ACCESS Newswire
    InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Announces Term Sheet for CAD$5 Million Private Placement
    Via Investor Brand Network
    NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advances ONC010 Manufacturing Development With Nanosoft
    Via Investor Brand Network
    News headline image
    Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
    From Onco-Innovations Limited
    Via ACCESS Newswire
    News headline image
    Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
    From Onco-Innovations Limited
    Via ACCESS Newswire
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Manufacturing and Development Efforts as It Pursues a Novel Approach to Hard-to-Treat Cancers
    Via Investor Brand Network
    News headline image
    Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
    From Onco-Innovations Limited
    Via ACCESS Newswire
    NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in NetworkNewsAudio Editorial on DNA Repair Therapies
    Via Investor Brand Network
    News headline image
    NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development
    From NetworkNewsWire
    Via GlobeNewswire
    News headline image
    InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on Emerging DNA Repair Inhibitors
    Via Investor Brand Network
    News headline image
    Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
    From Onco-Innovations Limited
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.